Cyd dengue virus serotype 1 live (attenuated) antigen

Star0

DB15521ApprovedInvestigationalWithdrawnVaccines

Cyd dengue virus serotype 1 live (attenuated) antigen: Overview.

First approval: United States, 2019

Resolves to

Compound

UNII75KB2HPX5H

Clinical / RWD

RxNorm2197290

What you can answer from here — as of September 01, 2026

7Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

13Marketed productsAcross 4 countries and 4 labellers

Which other approved drugs treat the same conditions as Cyd dengue virus serotype 1 live (attenuated) antigen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account